We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£520.00
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in the United States
Price data last checked 150 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£520 today · cheaper than every other day in the last 8 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 99 days • 99 data points (No recent data available)
Price Distribution
Price distribution over 99 days • 1 price levels
Price Analysis
Most common price: £520 (99 days, 100.0%)
Price range: £520 - £520
Price levels: 1 different prices over 99 days
Product Specifications
- Format
- paperback
- ASIN
- B0BLQLR9LF
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 09 November 2022
Similar Products You Might Like
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in India
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2026-2031 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2025-2030 World Outlook for Immune-Oncology Treatments
The 2025-2030 World Outlook for Immuno Oncology Assays
The 2023-2028 Outlook for Cancer Supportive Care in the United States
The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2021-2026 World Outlook for Silent Cancer Therapeutics
The 2023-2028 Outlook for Cancer Vaccines in India
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in the United States
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2023-2028 Outlook for Cancer Vaccines in the United States
The 2016-2021 Outlook for Cancer Therapies in North America & the Caribbean
